Pfizer Agrees to Purchase ReViral Ltd. For Up To $525-Million
Pfizer Inc., has now agreed for purchasing the respiratory antiviral drug producing company ‘ReViral Ltd.’ For a sum of 525 million dollars as the latest move of the company in the one-time overlooked field of the infectious disease. The company ‘ReViral Ltd.’ Based in the United Kingdom has been developing the therapies for the respiratory […]
Continue Reading